{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:37:45Z","timestamp":1789684665344,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.cmi.2019.11.020","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T05:45:39Z","timestamp":1575524739000},"page":"943.e1-943.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries"],"prefix":"10.1016","volume":"26","author":[{"given":"N.","family":"Babu Rajendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.T.","family":"Mutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Marasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sifakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.11.020_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1469-0691.2005.01083.x","article-title":"Surveillance and control of infectious diseases at local, national and international levels","volume":"11","author":"Weinberg","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.11.020_bib2","series-title":"Disease control priorities in developing countries","first-page":"997","article-title":"Public health surveillance: a tool for targeting and monitoring interventions","author":"Nsubuga","year":"2006"},{"key":"10.1016\/j.cmi.2019.11.020_bib3","series-title":"Infectious disease surveillance","first-page":"3","article-title":"Infectious disease surveillance: a cornerstone for prevention and control","author":"M'ikanatha","year":"2013"},{"key":"10.1016\/j.cmi.2019.11.020_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1198-743x.2001.00239.x","article-title":"Surveillance of antimicrobial resistance\u2014what, how and whither?","volume":"7","author":"Bax","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.11.020_bib5","series-title":"Review on antimicrobial resistance. Tackling drug-resistant infections globally: final report and recommendations","author":"O'Neill","year":"2014"},{"key":"10.1016\/j.cmi.2019.11.020_bib6","doi-asserted-by":"crossref","first-page":"ofv035","DOI":"10.1093\/ofid\/ofv035","article-title":"The control of methicillin-resistant Staphylococcus aureus blood stream infections in England","volume":"2","author":"Duerden","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2019.11.020_bib7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/jac\/dkr561","article-title":"Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years","volume":"67","author":"Johnson","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.11.020_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13756-017-0259-z","article-title":"Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control","volume":"6","author":"Magiorakos","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2019.11.020_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cmi.2017.07.014","article-title":"The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information","volume":"24","author":"Nunez-Nunez","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.11.020_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.11.020_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1017\/S0950268805005765","article-title":"Publication bias in foodborne outbreaks of infectious intestinal disease and its implications for evidence-based food policy. England and Wales 1992\u20132003","volume":"134","author":"O'Brien","year":"2006","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2019.11.020_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QCO.0000000000000182","article-title":"The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria","volume":"28","author":"Perez","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2019.11.020_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S0950268807008230","article-title":"Under-reporting of notifiable infectious disease hospitalizations in a health board region in Ireland: room for improvement?","volume":"136","author":"Brabazon","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2019.11.020_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2807\/esm.10.01.00512-en","article-title":"Mandatory disease reporting by German laboratories: a survey of attitudes, practices and needs","volume":"10","author":"Zucs","year":"2005","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2019.11.020_bib18","doi-asserted-by":"crossref","first-page":"19281","DOI":"10.2807\/ese.14.30.19281-en","article-title":"Validity of routine surveillance data: a case study on Swedish notifications of methicillin-resistant Staphylococcus aureus","volume":"14","author":"Stenhem","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2019.11.020_bib19","doi-asserted-by":"crossref","first-page":"30003","DOI":"10.2807\/1560-7917.ES.2015.20.34.30003","article-title":"To notify or not to notify: decision aid for policy makers on whether to make an infectious disease mandatorily notifiable","volume":"20","author":"Bijkerk","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2019.11.020_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drup.2015.05.001","article-title":"Carbapenemase-producing Enterobacteriaceae in Sweden 2007\u20132013: experiences from seven years of systematic surveillance and mandatory reporting","volume":"20","author":"Lofmark","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2019.11.020_bib21","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3201\/eid2407.151830","article-title":"Strengthening global public health surveillance through data and benefit sharing","volume":"24","author":"Edelstein","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.11.020_bib22","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/S1473-3099(17)30485-1","article-title":"Surveillance for control of antimicrobial resistance","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19306202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19306202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:26:11Z","timestamp":1761117971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19306202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1198743X19306202"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.11.020","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}